Page last updated: 2024-10-30

labetalol and Experimental Spinal Cord Ischemia

labetalol has been researched along with Experimental Spinal Cord Ischemia in 1 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"We present an unusual case of spinal cord ischemia from an acute type B intramural hematoma that was successfully treated with blood pressure elevation and drainage of cerebral spinal fluid."1.39Acute intramural hematoma of the aorta complicated by spinal cord ischemia. ( Cassiere, HA; Liang, D; Yu, PJ, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yu, PJ1
Cassiere, HA1
Liang, D1

Other Studies

1 other study available for labetalol and Experimental Spinal Cord Ischemia

ArticleYear
Acute intramural hematoma of the aorta complicated by spinal cord ischemia.
    Journal of cardiac surgery, 2013, Volume: 28, Issue:6

    Topics: Acute Disease; Administration, Oral; Adult; Antihypertensive Agents; Aortic Diseases; Blood Pressure

2013